Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, medical device, food and beverage, industrial hygiene, and environmental air sampling industries. Its Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and testing services. This segment also distributes chemical indicators that are used to assess the effectiveness of sterilization processes; and cleaning indicators, which are used to assess the effectiveness of cleaning processes. The company's Cold Chain Monitoring segment offers systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments; parameter monitoring services for products in a cold chain; and consulting services. Its Cold Chain Packaging segment offers packaging development consulting services and thermal packaging products. The company markets its products through distributors in Europe, Africa, Asia, South America, Australia, Canada, and Central America. Mesa Laboratories, Inc. was founded in 1982 and is headquartered in Lakewood, Colorado.
Industry, Sector and Symbol
Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
SectorMedical
Phone303-987-8000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$96.18 million
Profitability
Miscellaneous
Employees366
OptionableNot Optionable
Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions
What is Mesa Laboratories' stock symbol?
Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."
How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?
Mesa Laboratories announced a quarterly dividend on Wednesday, January 2nd. Shareholders of record on Thursday, February 28th will be paid a dividend of $0.16 per share on Friday, March 15th. This represents a $0.64 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend is Wednesday, February 27th. View Mesa Laboratories' Dividend History.
How were Mesa Laboratories' earnings last quarter?
Mesa Laboratories, Inc. (NASDAQ:MLAB) issued its earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.87 earnings per share for the quarter, beating the consensus estimate of $0.73 by $0.14. The medical instruments supplier earned $24.87 million during the quarter, compared to analyst estimates of $25 million. Mesa Laboratories had a return on equity of 23.53% and a net margin of 9.98%. View Mesa Laboratories' Earnings History.
When is Mesa Laboratories' next earnings date?
Has Mesa Laboratories been receiving favorable news coverage?
Media headlines about MLAB stock have trended positive on Tuesday, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Mesa Laboratories earned a news sentiment score of 2.3 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future.
Who are some of Mesa Laboratories' key competitors?
Some companies that are related to Mesa Laboratories include Orbotech (ORBK), Rudolph Technologies (RTEC), Hurco Companies (HURC), Clearsign Combustion (CLIR), Hickok (HICKA), International Isotopes (INIS), Universal Detection Technology (UNDT), Sypris Solutions (SYPR), Electro-Sensors (ELSE), Schmitt Industries (SMIT), Winland (WELX), Elbit Vision Systems (EVSNF) and National Automation Services (NESV).
Who are Mesa Laboratories' key executives?
Mesa Laboratories' management team includes the folowing people:
- Mr. Gary M. Owens, CEO, Pres & Director (Age 51)
- Mr. John V. Sakys, Chief Financial Officer, Chief Accounting Officer, Sec. & Treasurer (Age 50)
- Mr. Gregory T. DiNoia, Sr. VP of Commercial Operations (Age 54)
- Ms. Helene R. Leone, Gen. Counsel
- Mr. Peter Jung, VP of Corp. Devel. & Strategy
Who are Mesa Laboratories' major shareholders?
Mesa Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Conestoga Capital Advisors LLC (12.63%), BlackRock Inc. (6.53%), Ranger Investment Management L.P. (4.06%), Kayne Anderson Rudnick Investment Management LLC (4.04%), Dimensional Fund Advisors LP (3.64%) and Atlanta Capital Management Co. L L C (3.24%). Company insiders that own Mesa Laboratories stock include David M Kelly, Evan Guillemin, Glenn E Adriance, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks, Robert V Dwyer and Seg Ventures, Llc. View Institutional Ownership Trends for Mesa Laboratories.
Which institutional investors are selling Mesa Laboratories stock?
MLAB stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Royce & Associates LP, Brown Advisory Inc., Barclays PLC, Bank of New York Mellon Corp, Thomson Horstmann & Bryant Inc., Bahl & Gaynor Inc. and MetLife Investment Advisors LLC. Company insiders that have sold Mesa Laboratories company stock in the last year include David M Kelly, Evan Guillemin, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.
Which institutional investors are buying Mesa Laboratories stock?
MLAB stock was bought by a variety of institutional investors in the last quarter, including Atlanta Capital Management Co. L L C, Ranger Investment Management L.P., BlackRock Inc., Massachusetts Financial Services Co. MA, Bank of America Corp DE, Conestoga Capital Advisors LLC, Northern Trust Corp and Public Employees Retirement System of Ohio. View Insider Buying and Selling for Mesa Laboratories.
How do I buy shares of Mesa Laboratories?
Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Mesa Laboratories' stock price today?
One share of MLAB stock can currently be purchased for approximately $232.00.
How big of a company is Mesa Laboratories?
Mesa Laboratories has a market capitalization of $897.38 million and generates $96.18 million in revenue each year. The medical instruments supplier earns $-2,960,000.00 in net income (profit) each year or $6.18 on an earnings per share basis. Mesa Laboratories employs 366 workers across the globe.
What is Mesa Laboratories' official website?
How can I contact Mesa Laboratories?
Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]
MarketBeat Community Rating for Mesa Laboratories (NASDAQ MLAB)
MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe MLAB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MLAB will underperform the S&P 500 over the long term. You may vote once every thirty days.
